
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
Eris Lifesciences | Dr Reddys | dermatology

').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
BENGALURU (Reuters) - Indian drugmaker Eris Lifesciences Ltd said on Thursday it had bought nine dermatology brands from Dr. Reddy's Laboratories Ltd in a 2.75 billion rupees ($33.24 million) deal, to expand in the cosmetic dermatology business.
The deal, to be paid in cash, is expected to be completed on or before March 31, Eris said in a stock exchange filing.
Eris and Dr. Reddy's did not immediately respond to Reuters' requests seeking the names of the dermatology brands.
The deal comes two months after Eris said it would acquire a portfolio of dermatology brands from Glenmark Pharmaceuticals Ltd for 3.4 billion rupees to deepen its presence in the anti-fungal and anti-psoriasis segments.
Eris' shares were trading 1.4% lower as of 2:33 p.m. IST and were headed for a sixth straight session of losses. They have fallen 9.2% since announcing the deal with Glenmark.
($1 = 82.7250 Indian rupees)
(Reporting by Yagnoseni Das and Hritam Mukherjee in Bengaluru; Editing by Rashmi Aich and Eileen Soreng)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Thu, March 16 2023. 16:30 IST
There is something quietly symbolic about JPMorgan Chase choosing Berlin as its gateway into continental Europe. In a fo... Read more
There is a moment in every bull run when the narrative starts to fray. Not with a crash, not with a scandal, but with so... Read more
Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more
How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more
ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more
For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more